Suchergebnisse - "Šlechta, Petr"

PubPharm (4)

1

N-Pyrazinylhydroxybenzamides as biologically active compounds : a hit-expansion study and antimicrobial evaluation

enthalten in: Future medicinal chemistry | 2023

von Kerda, M. | Šlechta, P. | Jand'ourek, O. | +4

2

Correction to "Hybridization Approach Toward Novel Antituberculars : Design, Synthesis, and Biological Evaluation of Compounds Combining Pyrazinamide and 4-Aminosalicylic Acid"

enthalten in: ACS infectious diseases | 2023

von Bouz, G. | Šlechta, P. | Jand'ourek, O. | +14

ErratumFor: ACS Infect Dis. 2023 Jan 13;9(1):79-96. - PMID 36577009

3

Design, Synthesis and Antimicrobial Evaluation of New N-(1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase

enthalten in: International journal of molecular sciences | 2023

von Šlechta, P. | Needle, A. | Jand'ourek, O. | +7

4

Hybridization Approach Toward Novel Antituberculars : Design, Synthesis, and Biological Evaluation of Compounds Combining Pyrazinamide and 4-Aminosalicylic Acid

enthalten in: ACS infectious diseases | 2023

von Bouz, G. | Šlechta, P. | Jand'ourek, O. | +14

ErratumIn: ACS Infect Dis. 2023 Aug 11;9(8):1674. - PMID 37486740

1
[1]